Navigation Links
Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Apoptosis
Date:5/3/2011

yses their 204 identified drug targets, organized into 193 drug target strategies, and assesses them in eight different compound strategies and eight subindications of leukemia.

This part is based on the following publication:

A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market

Part III: Apoptosis

The apoptosis report part comprises defined and up to date development strategies for 171 apoptotic drugs in oncology (519 projects) within the portfolio of 125 investigators, from Ceased to Pre-registration. This report part extensively analyses 146 identified targets of apoptotic drugs, organized into 120 drug target strategies, and assesses them in 53 different cancer indications.

This part is based on the following publication:

Apoptotic Therapeutics in Oncology - Where to Commercialize?

The report is written for you to understand and assess the impact of competitor entry and corresponding changes to development strategies for your own portfolio products. It helps teams to maximize molecule value by selecting optimal development plans and manage risk and uncertainty. The report serves as an external commercial advocate for pharmaceutical companies' pipeline and portfolio planning (PPP) in cancer by:

* Providing you with competitive input to the R&D organization to guide development of early product ideas and ensure efforts are aligned with business objectives

* Assisting you to make informed decisions in selecting cancer indications that are known to be appropriate for your drug's properties

* Analyzing, correlating and integrating valuable data sources in order to provide accurate data for valuation of pipeline, in-licensing and new business opportunities

* Providing you with commercial analytic support for due diligence on in-licensing and acquisition opportunities

* Supporting development of integrative molecule, pathway and disea
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition
2. Reportlinker Adds Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer
3. Reportlinker Adds Cancer Reports Bundle
4. Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
5. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
6. Reportlinker Adds Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists Survey
7. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
8. Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
11. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 - ... R egistry data presented at ESC ... on the evolution of manag ing AF ... -   The first-ever two-year outcomes from the Global ... 2015 expose that all-cause death was the most frequent major event in more ...
(Date:9/1/2015)... Norway , September 1, 2015 ... biopharmaceutical company, today announces that it has appointed ... as Non-Executive Directors to its Board of Directors, effective ... 30 years of experience in pharma and biotech and ... Genzyme, a Sanofi company. Previously her role was Vice ...
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
Breaking Medicine Technology:Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9BerGenBio Appoints Non-Executive Directors 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3
... the ADA,s Annual Scientific Sessions, SAN FRANCISCO, ... of the dose-finding study for its new,injectable diabetes ... American Diabetes Association,s (ADA) 68th Annual Scientific Sessions,meeting ... that AVE0010 was well tolerated and significantly,improved glycemic ...
... California, June 6 , - "ADVANCE Results ... the world,s largest ever study of diabetes treatments,show ... release,gliclazide and other drugs as required, protects patients ... treatment reduces,the risk of kidney disease by one-fifth. ...
Cached Medicine Technology:New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 2New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 3New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 4The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications 2
(Date:9/1/2015)... , ... September 01, 2015 , ... Celebrity hairstylist and ... present “The Beauty Behind the Fashion” on Thursday, Oct. 1, at the La ... shine the spotlight on the collaboration between fashion and professional hair, makeup and nail ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... efficiently cure and prevent different malignancies. Some options for cancer treatment are ... due to which distinctive approach is necessary for effective treatment. Several molecules ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Extension Vending Machine,” is still strongly maintaining her firm’s success in the hair ... tools. In her upcoming city-to-city tour, Ellis will be providing “Look and learn” ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... and analysis of pet vital signs and activity, today announced its integration with ... the most popular and widely-adopted veterinary hospital Practice Management Software packages in the ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data ... new version of endpoint DLP developed specifically for Mac OS. , In June 2015, ... 100 IT and information security professionals had participated. The beta test done by the ...
Breaking Medicine News(10 mins):Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2
... sell patents to Life Spine, HOFFMAN ESTATES, Ill., ... Inc. announced today that it has acquired the,majority of ... transaction were not disclosed., According to Michael S. ... critical. "The core of the spine market,place is intellectual ...
... to,educate, inform and empower the people of Chicago, ... its 25-minute live,call-in show, "Community Health," on Chicago ... 6:00 PM on Channel 21., Monday,s program ... Deborah Edberg, MD, Attending Family Physician at NorthShore,University ...
... Therapy Treatment Takes Only Five Days, ARLINGTON, ... therapy following breast cancer surgery involves 30 sessions ... Accelerated Partial,Breast Irradiation (APBI), a newer radiation technology ... faster return to normal life, with,fewer side effects., ...
... New interim guidance,that outlines how to become ... the U.S. Department of Health and Human Services., ... (Patient Safety Act),authorized the creation of PSOs to ... on patient safety events. By providing both privilege,and ...
... 8 Quest Diagnostics,Incorporated (NYSE: DGX ), the ... today that its third-quarter,2008 results will be made public ... it will hold its quarterly conference call with investors,to ... that day., The public may access the conference ...
... a senior scientist emeritus and Corporation member at the ... Prize in Chemistry for his discovery of green fluorescent ... contemporary science and medicine for illuminating life at the ... was announced early today in Stockholm, with Martin Chalfie ...
Cached Medicine News:Health News:Women's Health - An Intimate Discussion 2Health News:Breast Cancer Patients Experience a Faster Return to Normal Life 2Health News:Breast Cancer Patients Experience a Faster Return to Normal Life 3Health News:HHS Issues Interim Guidance for Patient Safety Organizations 2Health News:Quest Diagnostics to Release Third Quarter 2008 Financial Results 2Health News:MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein 2Health News:MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein 3
The Gizmo male external catheter is a latex catheter that uses a single-sided adhesive strip....
Freedom Cath® is a latex, self-adhering, one-piece catheter designed for everyday wear....
... male external catheter is specially designed for the ... with a forward-placement adhesive band will work for ... may also be preferred when a longer sheath ... from a different adhesive location on their skin. ...
... Foley catheters eliminate patient exposure to ... designs. As an inert, toxin-free elastomer, ... safe, dependable Foley catheter. Unlike silicone-coated ... will not leach chemicals or water-soluble ...
Medicine Products: